Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report
TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV react...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2011/530568 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849407191475290112 |
|---|---|
| author | Michele Colaci Marco Sebastiani Gilda Sandri Marisa Meacci Clodoveo Ferri |
| author_facet | Michele Colaci Marco Sebastiani Gilda Sandri Marisa Meacci Clodoveo Ferri |
| author_sort | Michele Colaci |
| collection | DOAJ |
| description | TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab. |
| format | Article |
| id | doaj-art-45cf867feb6b44088680b3bcd60f9443 |
| institution | Kabale University |
| issn | 2090-6625 2090-6633 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Infectious Diseases |
| spelling | doaj-art-45cf867feb6b44088680b3bcd60f94432025-08-20T03:36:10ZengWileyCase Reports in Infectious Diseases2090-66252090-66332011-01-01201110.1155/2011/530568530568Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case ReportMichele Colaci0Marco Sebastiani1Gilda Sandri2Marisa Meacci3Clodoveo Ferri4Rheumatology Unit, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo 71, 41100 Modena, ItalyRheumatology Unit, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo 71, 41100 Modena, ItalyRheumatology Unit, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo 71, 41100 Modena, ItalyMicrobiology and Virology Service, Policlinico di Modena, Via del Pozzo 71, 41100 Modena, ItalyRheumatology Unit, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo 71, 41100 Modena, ItalyTNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.http://dx.doi.org/10.1155/2011/530568 |
| spellingShingle | Michele Colaci Marco Sebastiani Gilda Sandri Marisa Meacci Clodoveo Ferri Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report Case Reports in Infectious Diseases |
| title | Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report |
| title_full | Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report |
| title_fullStr | Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report |
| title_full_unstemmed | Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report |
| title_short | Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report |
| title_sort | epstein barr virus reactivation after infliximab in rheumatoid arthritis a case report |
| url | http://dx.doi.org/10.1155/2011/530568 |
| work_keys_str_mv | AT michelecolaci epsteinbarrvirusreactivationafterinfliximabinrheumatoidarthritisacasereport AT marcosebastiani epsteinbarrvirusreactivationafterinfliximabinrheumatoidarthritisacasereport AT gildasandri epsteinbarrvirusreactivationafterinfliximabinrheumatoidarthritisacasereport AT marisameacci epsteinbarrvirusreactivationafterinfliximabinrheumatoidarthritisacasereport AT clodoveoferri epsteinbarrvirusreactivationafterinfliximabinrheumatoidarthritisacasereport |